An Introduction to Randomisation in Clinical Trials [Video]

Learn what randomisation in clinical trials is, why it matters, and the key methods used to keep study results fair, unbiased, and reliable.

Randomisation is a cornerstone of clinical trial design, ensuring that participants are allocated to treatment groups in a fair and unbiased way. In this video, we’ll explain why randomisation matters, how it reduces bias and supports blinding, and the main methods used—simple, block, and stratified randomisation. We’ll also touch on unequal allocation and adaptive approaches, highlight the safeguards needed in multi-centre trials, and share common pitfalls to avoid.

At Quanticate, our biostatistics and data management teams have extensive experience in planning and implementing robust randomisation strategies. From writing specifications and generating schedules to setting up centralised systems, emergency unblinding procedures, and ongoing quality control, we help sponsors deliver reliable, audit-ready trials that stand up to regulatory scrutiny. Submit an RFI today.